ATLANTA, Sept. 27, 2010 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Company will present at the following investor conferences:
- Citi's 5 th Annual Biotech Day to be held October 5, 2010 at the Westin Boston Waterfront Hotel. Ken Green, Ph.D., Senior Vice President and Chief Scientific Officer, will participate in a panel discussion titled "Eye Diseases: Novel Therapies for Wet AMD, Retinal Vein Occlusion and Diabetic Macular Edema". The presentation is scheduled for October 5, 2010 at 8:00 a.m. ET.
- The 9 th Annual BIO Investor Forum to be held October 5-6, 2010 at the Palace Hotel in San Francisco. Dan Myers, President and Chief Executive Officer, is scheduled to present on October 6, 2010 at 2:30 p.m. ET.
CONTACT: Alimera Sciences, Inc. Richard S. Eiswirth, Jr., Chief Financial Officer 678.527.1750 ICR, Inc. Donald Ellis 925.253.1240